CRABP2 and breast neoplasm: Analysis of a qPCR array consisting of cDNA derived from samples of normal breast and various stages of human breast tumors (OriGene) showed that downregulation of KLF2 during disease progression is correlated with a marked decrease in the ratio of CRABP2 and FABP5 mRNAs (Figure 2B).